Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy
Abstract
Objective: To identify cognitive and MRI features important for the clinical diagnosis of corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP); these diseases share several clinical features and are often difficult to distinguish on clinical grounds.
Methods: Cognitive functions and MRI characteristics were examined in 16 patients with CBD and 28 patients with PSP, all diagnosed according to current clinical criteria (none was examined by autopsy).
Results: MRI findings differed significantly between the two groups: 87.5% of patients with CBD but none with PSP had asymmetric frontoparietal atrophy, whereas 89.3% of patients with PSP but only 6.3% of those with CBD had midbrain atrophy. Cognitive examination showed that ideomotor apraxia (De Renzi’s test) was significantly more frequent in CBD, and executive functions (Nelson’s test) were significantly more impaired in patients with PSP.
Conclusions: MRI findings of asymmetric frontoparietal atrophy in CBD and midbrain atrophy in PSP are the most consistent and useful aids to careful clinical evaluation for differentiating between the two diseases.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Davis PH, Bergeron C, McLachlan DR. Atypical presentation of progressive supranuclear palsy. Ann Neurol 1985;17:337–343.
2.
Bergeron C, Pollanen MS, Weyer L, Black SE, Lang AE. Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 1996;40:893–900.
3.
Lippa CF, Cohen R, Smith TW, Drachman DA. Primary progressive aphasia with focal neuronal achromasia. Neurology 1991;41:882–886.
4.
Gearing M, Olson DA, Watts RL, Mirra SS. Progressive supranuclear palsy : neuropathologic and clinical heterogeneity. Neurology 1994;44:1015–1024.
5.
Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration : neuropathologic and clinical heterogeneity. Neurology 1997;48:959–969.
6.
Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick’s disease and corticobasal degeneration. J Neuropathol Exp Neurol 1996;55:53–67.
7.
Litvan I, Agid Y, Goetz CG, et al. Accuracy of the clinical diagnosis of corticobasal degeneration : a clinicopathologic study. Neurology 1997;48:119–125.
8.
Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) : report of the NINDS-SPSP International Workshop. Neurology 1996;47:1–9.
9.
Pillon B, Dubois B, Agid Y. Testing cognition may contribute to the diagnosis of movement disorders. Neurology 1996;46:329–334.
10.
Savoiardo M, Girotti F, Strada L, Ciceri E. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm 1994;42 (suppl):93–110.
11.
Litvan I, Campbell G, Mangone CA, et al. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 1997;120:65–74.
12.
Fahn S, Elton R. Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent developments in Parkinson’s disease. Vol. II.Florham Park, NJ:MacMillan Healthcare Information, 1987:153–163.
13.
American Psychiatric Association.Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC:American Psychiatric Association, 1994.
14.
Folstein MF, Folstein SE, McHugh PR. Mini Mental State : a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
15.
Raven JC. Guide to using the colored progressive matrices. London:HK Lewis, 1965.
16.
Randt CT, Brown ER, Osborne DP. A memory test for longitudinal measurement of mild to moderate deficits. Clin Neuropsychol 1980;2:184–194.
17.
Benton AL, Varney NR, Hamsher KS. Visuo-spatial judgment : a clinical test. Arch Neurol 1978;35:364–367.
18.
Nelson HE. Modified card sorting test sensitive to frontal lobe defects. Cortex 1976;12:313–324.
19.
Novelli G, Papagno C, Capitani E, Laiacona M, Vallar G, Cappa SF. Tre test clinici di ricerca e produzione lessicale : taratura su soggetti normali. Archivio di Psicologia Neurologia e Psichiatria. 1986;47:477–506.
20.
De Renzi E, Motti F, Nichelli P. Imitating gestures : a quantitative approach to ideomotor apraxia. Arch Neurol 1980;37:6–10.
21.
Basso A, Capitani E, Laiacona M. Raven’s coloured progressive matrices : normative values on 305 adult normal controls. Funct Neurol 1987;2:189–194.
22.
Meazzo G, Cavarzeran F, Zappalà G, et al. The Mini Mental State Examination normative study of an Italian random sample. Dev Neuropsychol 1993;9 (2):77–85.
23.
Spinnler H, Tognoni G, Gruppo Italiano per lo Studio Neuropsicologico dell’Invecchiamento. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 1987(suppl 8).
24.
Oldfield RC. The assessment and analysis of handedness : the Edinburgh Inventory. Neuropsychologia 1971;9:97–113.
25.
Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy : a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333–358.
26.
Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20–33.
27.
Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration : a clinical study of 36 cases. Brain 1994;117:1183–1196.
28.
Daniel SE, de Bruin VMS, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy) : a reappraisal. Brain 1995;118:759–777.
29.
Grisoli M, Fetoni V, Savoiardo M, Girotti F, Bruzzone MG. MRI in corticobasal degeneration. Eur J Neurol 1995;2:547–552.
30.
Pillon B, Blin J, Vidailhet M, et al. The neuropsychological pattern of corticobasal degeneration : comparison with progressive supranuclear palsy and Alzheimer’s disease. Neurology 1995;45:1477–1483.
31.
Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological functioning in cortical-basal ganglionic degeneration : differentiation from Alzheimer’s disease. Neurology 1996;46:720–726.
32.
Leiguarda R, Lees AJ, Merello M, Starkstein S, Marsden CD. The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry 1994;57:455–459.
33.
Heilman KM, Rothi LJG, Valenstein E. Two forms of ideomotor apraxia. Neurology 1982;32:342–346.
34.
Denes G, Mantovan MC, Gallana A, Cappelletti JY. Limb-kinetic apraxia. Mov Disord 1998;13:468–476.
35.
Heilman KM, Rothi LJG. Apraxia. In: Heilman KM, Valenstein E, eds. Clinical neuropsychology. 2nd ed. New York:Oxford University Press, 1985:131–150.
36.
Freund HJ. The apraxias. In: Asbury AK, McKhann GM, McDonald WJ, eds. Diseases of the nervous system. Clinical neurobiology. 2nd ed. Philadelphia:Saunders, 1992:751–767.
37.
Lantos PL. The neuropathology of progressive supranuclear palsy. J Neural Transm 1994;42 (suppl):137–152.
38.
Brooks DJ. PET studies in progressive supranuclear palsy. J Neural Transm 1994;42 (suppl):119–134.
39.
Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathological criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97–105.
40.
Neary D. Frontotemporal degeneration, Pick disease, and corticobasal degeneration : one entity or three? Arch Neurol 1997;54:1425–1427.
Information & Authors
Information
Published In
Copyright
© 1999.
Publication History
Received: January 20, 1999
Accepted: March 20, 1999
Published online: August 1, 1999
Published in print: August 1, 1999
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Usefulness of Olfactory Bulb Measurement in 3D-FIESTA in Differentiating Parkinson Disease from Atypical Parkinsonism, American Journal of Neuroradiology, 45, 8, (1141-1152), (2024).https://doi.org/10.3174/ajnr.A8275
- Neuroimaging in corticobasal syndrome, Neuroimaging in Parkinson�s Disease and Related Disorders, (399-417), (2023).https://doi.org/10.1016/B978-0-12-821651-4.00012-9
- Glymphatic system impairment in corticobasal syndrome: diffusion tensor image analysis along the perivascular space (DTI-ALPS), Japanese Journal of Radiology, 41, 11, (1226-1235), (2023).https://doi.org/10.1007/s11604-023-01454-7
- Appropriate Use of Biomarkers in Suspected Neurodegenerative Diseases, Molecular Imaging of Neurodegenerative Disorders, (15-34), (2023).https://doi.org/10.1007/978-3-031-35098-6_2
- Clinical Spectrum of Tauopathies, Frontiers in Neurology, 13, (2022).https://doi.org/10.3389/fneur.2022.944806
- Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn), Frontiers in Neurology, 13, (2022).https://doi.org/10.3389/fneur.2022.814768
- Radiological assessment of dementia: the Italian inter-society consensus for a practical and clinically oriented guide to image acquisition, evaluation, and reporting, La radiologia medica, (2022).https://doi.org/10.1007/s11547-022-01534-0
- The Cognitive Profile of Atypical Parkinsonism: A Meta-Analysis, Neuropsychology Review, 33, 2, (514-543), (2022).https://doi.org/10.1007/s11065-022-09551-6
- Arterial spin labeling imaging for the detection of cerebral blood flow asymmetry in patients with corticobasal syndrome, Neuroradiology, 64, 9, (1829-1837), (2022).https://doi.org/10.1007/s00234-022-02942-9
- Diagnosis and treatment of old-onset Parkinson's disease高齢発症パーキンソン病の診断と治療, Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 58, 3, (341-352), (2021).https://doi.org/10.3143/geriatrics.58.341
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.